May E. Venturanza

32 papers receiving 479 citations

May E. Venturanza's Hit Papers

Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies 2021 · 245 citations
2450+1+3Years since publication50100150200

Peers

May E. Venturanza
Comparison fields: 5 of 28
  • Dermatology 424
  • Pharmaceutical Science 14
  • Toxicology 8
  • Oncology 27
  • Immunology and Allergy 6
Replace Hiroshi Komazaki with:
Hiroshi Komazaki Japan
Yu Sung Choi South Korea
Masataka FURUE Japan
Alan Greenspan United States
Raheel Zubair United States
Setsuko Ueda Japan
Lorne E. Albrecht Canada
Alan Rosenbach United States
F Lisa Italy
Teppei Hagino Japan
May E. Venturanza relative to Hiroshi Komazaki Japan Hiroshi Komazaki's profile →
Citations per field
00.5×2×4×6.8×
Hiroshi Komazaki · 1×
Citations per year

Countries citing papers authored by May E. Venturanza

Since Specialization
Citations

This map shows the geographic impact of May E. Venturanza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by May E. Venturanza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites May E. Venturanza more than expected).

Fields of papers citing papers by May E. Venturanza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by May E. Venturanza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by May E. Venturanza. The network helps show where May E. Venturanza may publish in the future.

Co-authors

The 25 scholars most cited alongside May E. Venturanza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with May E. Venturanza Line = papers co-authored together May E. Venturanza links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies
Hit paper breakdown →
2021245
2 202089
3 202018
4 202218
5 202216
6 202413
7 202111
8 202211
9 20219
10 20216
11 20215
12 20215
13 20225
14 20194
15 20214
16 20214
17 20214
18 20214
19 20213
20 20213

About May E. Venturanza

May E. Venturanza is a scholar working on Dermatology, Nuclear Energy and Engineering, Waste Management and Disposal, Infectious Diseases and Organic Chemistry, having authored 33 papers that have together received 493 indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (33 papers). The work is most often cited by research in Dermatology (424 citations), Pharmaceutical Science (14 citations), Toxicology (8 citations), Oncology (27 citations) and Immunology and Allergy (6 citations). May E. Venturanza has collaborated with scholars based in United States, Canada and Poland. Frequent co-authors include Michael E. Kuligowski, Kang Sun, Kim Alexander Papp, Eric Lawrence Simpson, Leon Kircik, Jacek Cezary Szepietowski, Lawrence F. Eichenfield, Darryl P. Toth, Seth B. Forman and Donald Y.M. Leung. Their work appears in journals such as Journal of the American Academy of Dermatology, Journal of Investigative Dermatology, American Journal of Clinical Dermatology, Annals of Allergy Asthma & Immunology and Journal of Allergy and Clinical Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact